Wix.com Ltd. WIX 深 沪
已收盘 05-08 16:00:00 美东时间
80.12
-0.220
-0.27%
华盛通- 最 高80.665
- 今 开78.90
- 成交量 156.56万股
- 最 低 74.505
- 昨 收 80.34
- 总市值 46.72亿
- 52周最高 190.93
- 市盈率 静 91.30
- 换手率 2.68%
- 52周最低 60.22
- 委 比 -68.94%
- 总股本 5831.42万
- 历史最高 362.07
- 量 比 1.29
- 振 幅 7.67%
- 历史最低 14.28
- 每 手 1
- 风险率 35.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wix to Participate in Fireside Chat at the 2026 Jefferies Software, Internet, and AI Conference
Wix.com Ltd. announced that its management will participate in a fireside chat at the 2026 Jefferies Software, Internet, and AI Conference on May 27, 2026, at 12 pm PDT (9:00 am EDT). The event will be available via live audio webcast and archived replay on Wix's investor relations website: https://investors.wix.com. Wix, founded in 2006 and strengthened by the 2025 acquisition of Base44, aims to simplify complex technologies and deliver the best...
05-06 13:00
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
B of A Securities Maintains Buy on Wix.com, Lowers Price Target to $109
B of A Securities analyst Michael McGovern maintains Wix.com (NASDAQ:WIX) with a Buy and lowers the price target from $136 to $109.
04-21 21:34
Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainers include AVEX, CMPS, ATAI, GHRS, POET, SILA, BLD, INV, MXL, KSPI.
04-20 22:34
美股周涨跌榜 | 复刻史诗级轧空行情？安飞士周内狂涨超57%；光通信概念股持续获资金青睐！应用光电周涨超44%
复刻史诗级轧空行情？安飞士周内狂涨超57%；光通信概念股持续获资金青睐！应用光电周涨超44%；Claude管理智能体冲击应用软件股，Snowflake周内跌超20%>>
04-11 09:47
美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Barclays Maintains Overweight on Wix.com, Lowers Price Target to $155
Barclays analyst Trevor Young maintains Wix.com (NASDAQ:WIX) with a Overweight and lowers the price target from $160 to $155.
04-09 20:53
Citizens Downgrades Wix.com to Market Perform
Citizens analyst Andrew Boone downgrades Wix.com (NASDAQ:WIX) from Market Outperform to Market Perform.
04-07 21:46
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
